Discover 290 paid clinical trials in Cape Coral, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 290
Active & Responsive
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Port Charlotte FL
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07141329
Phase2, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Port Charlotte FL, Largo FL, Tampa FL, Clearwater FL,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
for
Lung Diseases, Interstitial
Location: Venice FL
Sponsor: Maule Stem Cell Research Institute, Inc.
Sex: All
Age: 18+
Code: NCT07372989
Phase1, Recruiting
Active & Responsive
Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery
for
Astigmatism
Location: Venice FL, Mt. Pleasant SC
Sponsor: Center For Sight
Sex: All
Age: 21+
Code: NCT07140653
Recruiting
Active & Responsive
Odyssey Evaluation in Post LASIK Patients
for
Cataract
Location: Venice FL
Sponsor: Center For Sight
Sex: All
Age: 50+
Code: NCT07260695
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
for
Sjogren Syndrome With Keratoconjunctivitis
Location: Venice FL
Sponsor: Center For Sight
Sex: All
Age: 18+
Code: NCT07277257
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Venice FL, N. Venice FL, Sarasota FL, Augusta GA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens
for
Age Related Cataracts
Location: Cape Coral FL, Gainesville GA, Torrance CA
Sponsor: Argus Research Center, Inc.
Sex: All
Age: 0+
Code: NCT07006428
Recruiting
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
for
Graves Disease
Location: Fort Myers FL, Tampa FL, Hialeah FL, Doral FL,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 70
Code: NCT07661056
Phase3, Recruiting
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy
for
Radiculopathy Lumbar, Radiculopathy Sacral,
Location: Fort Myers FL, Cape Coral FL, Clearwater FL,
Sponsor: NeuFit - Neurological Fitness and Education
Sex: All
Age: 18+
Code: NCT06421558
Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
for
COVID-19 SARS-CoV-2 Infection
Location: Fort Myers FL, St. Petersburg FL, Tampa FL,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT06679140
Phase3, Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for
Pneumococcal Disease
Location: Homestead FL, Tampa FL, North Lauderdale FL,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07629440
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Fort Myers FL, Port Charlotte FL, Sarasota FL, Tampa FL,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment